BRIEF-pSivida reports positive results from investigator-sponsored phase 2 study of Medidur

* Results from investigator-sponsored phase 2 study of Medidur showed no recurrence of uveitis in 11 eyes treated with Medidur in 2 years after implant Source text for Eikon: Further company coverage:
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.